FDA-approved Trial Evaluates AngioDynamics’ NanoKnife for Prostate Tissue Ablation

https://evtoday.com/news/angiodynamics-nanoknife-will-be-evaluated-for-prostate-tissue-ablation-in-fda-approved-preserve-pivotal-trial
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.